![](/img/cover-not-exists.png)
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
Herve, P, Flesch, M, Tiberghien, P, Wijdenes, J, Racadot, E, Bordigoni, P, Plouvier, E, Stephan, JL, Bourdeau, H, Holler, EVolume:
79
Journal:
Blood
DOI:
10.1182/blood.v79.12.3362.3362
Date:
June, 1992
File:
PDF, 731 KB
1992